Citro Pharma

Guelph, Canada
Global manufacturer and exporter of pharmaceuticals, biopharmaceuticals, and vaccines.

About Citro Pharma

Citro Pharma is a Healthcare company based in Guelph (Canada) by Kanti Mapara. Global manufacturer and exporter of pharmaceuticals, biopharmaceuticals, and vaccines. It operates on a B2B and Export model. Its Indian entity Citro Pharma Private Limited reported revenue of β‚Ή20.60 Cr. Citro Pharma offers products and services including Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and Vaccines. Its focus areas include Pharmaceuticals, Drugs, Oncology and Biosimilars and Biopharmaceuticals.

Company details

Citro Pharma, based in Canada, specializes in manufacturing and marketing a wide range of high-quality pharmaceutical and biopharmaceutical drugs, including oncology and biosimilars. They export products worldwide, partner with leading manufacturers, and focus on timely delivery and client satisfaction. The company operates in multiple countries, emphasizing affordable healthcare solutions through research and distribution.

  • Headquarters Guelph, Canada
  • Founders Kanti Mapara
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website citropharm.com
  • Legal Name Citro Pharma Private Limited
  • Date of Incorporation 14 Oct, 2016
  • Jurisdiction Bangalore, Karnataka, India
Operational Areas
Key Metrics
  • Indian entity revenue
    ₹20.60 Cr

    FY 2025 · +3% YoY

  • Indian entity net profit
    ₹2.62 Cr

    FY 2025 · 13% margin

  • Indian entity EBITDA
    ₹3.65 Cr

    FY 2025 · 18% margin

Products & Services of Citro Pharma

Citro Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and Vaccines.

Pharmaceutical Oral Solid Drugs
Drugs

Solid form medications for various treatments and diseases.

Generic Injectables
Injectables

Generic versions of injectable drugs for medical use.

Oncology
Cancer Treatment

Drugs targeting cancer therapy and related conditions.

Biosimilars
Biologics

Biological products similar to reference drugs.

Vaccines
Preventive Medicine

Vaccines for disease prevention and immunization.

Blood Related Products
Healthcare

Products like human albumin for blood-related treatments.

Board of directors of Citro Pharma Private Limited (Citro Pharma)

Citro Pharma Private Limited is the primary company behind Citro Pharma. The board of Citro Pharma Private Limited currently have 3 directors; the longest-serving is Shaikh Mukhtar Ahmed, appointed in 2016. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Shaikh Mukhtar Ahmed
DIN 07637161
Director14 Oct 201610 yrs 1 moCitro Pharma Private Limited
Mukhtar Ahmed
DIN 07637162
Director14 Oct 201610 yrs 1 moCitro Pharma Private Limited
Ashfaq Ahmed
DIN 07634546
Director14 Oct 201610 yrs 1 moCitro Pharma Private Limited

People of Citro Pharma

1 people are tracked at Citro Pharma (1 in leadership).

NameRoleGroup
Kanti Mapara
FounderLeadership
Premium access

Complete people profiles for Citro Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Citro Pharma

Figures of Citro Pharma Private Limited, the primary company behind Citro Pharma, for FY 2025. Revenue was ₹20.60 Cr (+3% year on year). Net profit was ₹2.62 Cr (13% margin). EBITDA was ₹3.65 Cr (18% margin). Revenue has grown at a compounded annual rate of +6% over three years and +18% over five years.

  • ₹20.60 CrRevenue · FY 2025 · +3% YoY
  • ₹2.62 CrNet profit · 13% margin
  • ₹3.65 CrEBITDA · 18% margin
  • ₹1 LakhPaid-up capital
  • +6%Revenue CAGR, 3 years
  • +18%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Citro Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Citro Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Citro Pharma

Citro Pharma is headquartered in Guelph, Canada. It is registered at Guelph, Ontario, Canada.

The primary company behind Citro Pharma, Citro Pharma Private Limited, reported revenue of β‚Ή20.60 Cr for FY 2025, up 3% year on year.

Citro Pharma, based in Canada, specializes in manufacturing and marketing a wide range of high-quality pharmaceutical and biopharmaceutical drugs, including oncology and biosimilars. They export products worldwide, partner with leading manufacturers, and focus on timely delivery and client satisfaction. The company operates in multiple countries, emphasizing affordable healthcare solutions through research and distribution.

Citro Pharma offers Pharmaceutical Oral Solid Drugs, Generic Injectables, Oncology, Biosimilars, and 2 more products and services.

Citro Pharma operates through Citro Pharma Private Limited.

The legal entities of Citro Pharma currently have 3 directors, including Shaikh Mukhtar Ahmed, Mukhtar Ahmed, Ashfaq Ahmed.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available